(E)-1-(3-CHLOROPHENYL)-3-DIMETHYLAMINOPROPENONE, 97.0%, 10g

(4-Methoxy-3-(piperidin-1-ylsulfonyl)phenyl)boronic acid, 95.0%, 250mg

Hesperidin>90.0%(HPLC)(T)25g

2-Amino-3-trifluoromethylpyridine, 98.0%, 5g

1-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 97.0%, 25g

2-(2,4-Difluorophenyl)-5-(trifluoromethyl)pyridine, 97.0%, 5g

2-(2,3-Dihydrothieno[3,4-b][1,4]dioxin-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

trans-4-(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol, 98%, 100mg

N-(3-Acetylphenyl)-3-aminobenzamide, 95.0%, 10g

Polyethylene Glycol Monomethyl Ether Methacrylate (n=approx. 9) (stabilized with MEHQ)500g

1-(1,2,3,4-TETRAHYDROQUINOLIN-6-YL)ETHANONE, 95.0%, 1g

4-[2-(4-quinolinyl)vinyl]phenol, 95.0%, 1g

3-(1-(tert-Butoxy)-2-methyl-1-oxopropan-2-yl)-5-methyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylic acid, 98%, 100mg